Custom Tetramer/PE - HLA-C*03:04 (IP)
Référence TSCM-3-C0304-1
Conditionnement : 50tests
Contactez votre distributeur local :
Please Note: MBL International will be shutting down its operations effective December 31, 2024. Distribution of MBL products in the United States will be transferred to Cosmo Bio US on January 1st while European Distributors will remain unchanged. For any US inquiries regarding orders or support during this transition, reach out to Cosmo Bio: https://www.cosmobiousa.com/. For Non-US inquiries reach out to MBL in Japan: https://www.mblbio.com/.
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
| Target | Custom |
|---|---|
| Product Type | Tetramer |
| Application | FCM |
| Conjugate | PE |
| Class | Class I |
| Species Reactivity | Human |
| Allele | HLA-C*03:04 |
| Peptide Sequence | MBL-supplied peptide |
| Research Area | Immunology, Immune Monitoring |
| Protocols | FCM |
| Specificity | Custom |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
TSCM-3-C0304-1
Tetramer
50 tests